You are here

  • Home
  • Archive
  • Volume 70, Issue Suppl 3
  • P150 Once-daily tiotropium Respimat® reduces risk of severe asthma exacerbation and asthma worsening in symptomatic asthma, independent of allergic and inflammatory status

Article metrics

Article menu

Download PDFPDF

Poster sessions
Asthma treatment
P150 Once-daily tiotropium Respimat® reduces risk of severe asthma exacerbation and asthma worsening in symptomatic asthma, independent of allergic and inflammatory status
Free

 

Online download statistics by month:

Online download statistics by month: November 2015 to March 2024

AbstractFullPdf
Nov 20152200
Dec 20151902
Jan 20162100
Feb 2016600
Mar 2016701
Apr 20162904
May 20161300
Jun 20161501
Jul 2016700
Aug 2016502
Sep 20161001
Oct 20161600
Nov 201617024
Dec 20161500
Jan 2017900
Feb 20171003
Mar 20171501
Apr 2017505
May 20172104
Jun 20171103
Jul 20173003
Aug 20171403
Sep 20173802
Oct 20171802
Nov 20171602
Dec 20171200
Jan 2018800
Feb 2018603
Mar 20181001
Apr 20181000
May 20181802
Jun 2018800
Jul 20181000
Aug 20181401
Sep 2018601
Oct 20181000
Nov 20181001
Dec 20181000
Jan 2019400
Feb 2019401
Mar 2019400
Apr 2019800
May 2019200
Jun 2019600
Aug 20191002
Sep 2019802
Oct 2019801
Nov 2019606
Dec 2019603
Jan 2020601
Feb 2020501
Mar 2020202
Apr 2020001
May 2020800
Jun 2020402
Jul 20201003
Aug 2020204
Sep 20201000
Oct 2020703
Nov 2020601
Dec 2020300
Jan 2021605
Feb 2021201
Mar 2021201
Apr 2021200
May 2021205
Jun 2021001
Jul 2021004
Aug 2021001
Sep 2021004
Oct 20214020
Nov 20216010
Dec 20211402
Jan 20221001
Feb 2022201
Mar 2022601
Apr 2022401
May 2022609
Jun 20221202
Jul 2022500
Aug 20221404
Sep 2022603
Oct 2022604
Nov 20221003
Dec 20221000
Jan 2023201
Feb 2023600
Mar 2023800
Apr 2023201
May 2023204
Jun 2023300
Jul 2023402
Aug 2023501
Sep 2023700
Oct 2023200
Nov 2023902
Dec 2023601
Jan 2024601
Feb 2024400
Mar 20244010
Total8490211